Recent advances in the molecular pathology of soft tissue sarcoma : Implications for diagnosis, patient prognosis, and molecular target therapy in the future

- ODA Yoshinao
- Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University
- TSUNEYOSHI Masazumi
- Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University

References (79)
Cited by (1)

Search this Article

Author(s)

- ODA Yoshinao
- Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University
- TSUNEYOSHI Masazumi
- Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University

Journal

Cancer Sci

Cancer Sci 100(2), 200-208, 2009-02-10

References: 79

1

<no title>

FLETCHER CDM eds

World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone, 2002

Cited by (1)
2

PAX3-FKHR and PAX7-FKHR gene fusions are prognostic factors in alveolar rhabdomyosarcoma : a report from the Children's Oncology Group

SORENSEN PHB

J Clin Oncol 20, 2672-2679, 2002

Cited by (1)
3

Detection of COL1A1-PDGFB fusion transcripts and PDGFB/PDGFRB expresssion in dermatofibrosarcoma protuberans

TAKAHIRA T

Mod Pathol 20, 668-675, 2007

Cited by (1)
4

Does expression of different EWS chimeric transcripts define clinically distinct risk groups of Ewing tumor patients?

ZOUBEK A

J Clin Oncol 14, 1245-1251, 1996

Cited by (1)
5

EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma

DE ALAVA E

J Clin Oncol 16, 1248-1255, 1998

Cited by (1)
6

Association of EWS-FLI1 type 1 fusion with lower proliferative rate in Ewing's sarcoma

DE ALAVA E

Am J Pathol 156, 849-855, 2000

Cited by (1)
7

Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma : a multi-institutional retrospective study of 243 patients

LADANYI M

Cancer Res 62, 135-140, 2002

Cited by (1)
8

Molecular abnormalities of the p53 pathway in dedifferentiated liposarcoma

DEI TOS AP

J Pathol 181, 8-13, 1997

Cited by (1)
9

Nuclear immunoreaction of p53 protein in soft tissue sarcomas. A possible prognostic factor

KAWAI A

Cancer 73, 2499-2505, 1994

Cited by (1)
10

Leiomyosarcoma in soft tissue : examination of p53 status and cell proliferating factors in different locations

KONOMOTO T

Hum Pathol 29, 74-81, 1998

Cited by (1)
11

Alterations of cell cycle regulators in localized synovial sarcoma : a multifactorial study with prognostic implications

ANTONESCU CR

Am J Pathol 156, 977-983, 2000

Cited by (1)
12

Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma : a molecular and clinicopathologic study of 82 cases

ANTONESCU CR

Clin Cancer Res 7, 3977-3987, 2001

Cited by (1)
13

Frequent alteration of p16INK4a/p14ARF and p53 pathways of round cell appearance in myxoid/round cell liposarcoma : altered p53 gene and reduced p14ARF expression correlates with poor prognosis

ODA Y

J Pathol 207, 410-421, 2005

Cited by (1)
14

Prognostic impact of P53 status in Ewing sarcoma

DE ALAVA E

Cancer 89, 783-792, 2000

Cited by (1)
15

Microsatellite instability and p53 mutation associate with tumor progression in dermatofibrosarcoma protuberans

TAKAHIRA T

Hum Pathol 35, 240-245, 2004

Cited by (1)
16

mdm2 mRNA level is a prognostic factor in soft tissue sarcoma

TAUBERT H

Mol Med 6, 50-59, 2000

Cited by (1)
17

Mechanisms of inactivation of the p16 gene in leiomyosarcoma of soft tissue : The absence of p16 expression correlates with the methylation status and poor prognosis

KAWAGUCHI K

J Pathol 201, 487-495, 2003

Cited by (1)
18

Alterations of the RB1 gene in dedifferentiated liposarcoma

TAKAHIRA T

Mod Pathol 18, 1461-1470, 2005

Cited by (1)
19

Death-associated protein kinase (DAP kinase) alteration in soft tissue leiomyosarcoma : Promoter methylation or homozygous deletion is associated with a loss of DAP kinase expression

KAWAGUCHI K

Hum Pathol 35, 1266-1271, 2004

Cited by (1)
20

Alterations of cancer-related genes in soft tissue sarcomas : hypermethylation of RASSF1A is frequently detected in leiomyosarcoma and associated with poor prognosis in sarcoma

SEIDEL C

Int J Cancer 114, 442-447, 2005

Cited by (1)
21

Aberrant expression of CHFR in malignant peripheral nerve sheath tumors

KOBAYASHI C

Mod Pathol 19, 524-532, 2006

Cited by (1)
22

Alterations of cell cycle regulators in myxofibrosarcoma. With special emphasis on their prognostic implications

ODA Y

Hum Pathol 34, 1035-1042, 2003

Cited by (1)
23

Expression of epidermal growth factor receptor, ERBB2 and KIT in adult soft tissue sarcomas : a clinicopathologic study of 281 cases

SATO O

Cancer 103, 1881-1890, 2005

Cited by (1)
24

Expression of hepatocyte growth factor (HGF)/scatter factor and its receptor c-MET correlates with poor prognosis in synovial sarcoma

ODA Y

Hum Pathol 31, 185-192, 2000

Cited by (1)
25

P-glycoprotein expression in soft-tissue sarcomas

NAKANISHI H

J Cancer Res Clin Oncol 123, 352-356, 1997

Cited by (1)
26

Multidrug resistance phenotype in high grade soft tissue sarcoma : correlation of P-glycoprotein immunohistochemistry with pathologic response to chemotherapy

JIMENEZ RE

Cancer 86, 976-981, 1999

Cited by (1)
27

ATP-binding cassette superfamily transporter gene expression in human soft tissue sarcomas

ODA Y

Int J Cancer 114, 854-862, 2005

Cited by (1)
28

Expression of multidrug-resistance-associated protein gene in human soft-tissue sarcomas

ODA Y

J Cancer Res Clin Oncol 122, 161-165, 1996

Cited by (1)
29

Nuclear expression of Y-box-binding protein-1 correlates with P-glycoprotein and topoisomerase II alpha expression, and with poor prognosis in synovial sarcoma

ODA Y

J Pathol 199, 251-258, 2003

Cited by (1)
30

Prognostic value of the preserved expression of the E-cadherin and catenin families of adhesion molecules and of beta-catenin mutations in synovial sarcoma

SAITO T

J Pathol 192, 342-350, 2000

Cited by (1)
31

Prognostic significance of dysadherin expression in epithelioid sarcoma and its diagnostic utility in distinguishing epithelioid sarcoma from malignant rhabdoid tumor

IZUMI T

Mod Pathol 19, 820-831, 2006

Cited by (1)
32

Dysadherin expression as a significant prognostic factor and as a determinant of histologic features in synovial sarcoma : special reference to its inverse relationship with E-cadherin expression

IZUMI T

Am J Surg Pathol 31, 85-94, 2007

Cited by (1)
33

Induction of p21 (WAF1/CIP1) by human synovial sarcoma-associated chimeric oncoprotein SYT-SSX1

TSUDA M

Oncogene 24, 7984-7990, 2005

Cited by (1)
34

The SYT-SSX1 fusion type of synovial sarcoma is associated with increased expression of cyclin A and D1. A link between t(X;18) (p11.2;q11.2) and the cell cycle machinery

XIE Y

Oncogene 21, 5791-5796, 2002

Cited by (1)
35

The possible role of EWS-Fli1 in evasion of senescence in Ewing family tumors

MATSUNOBU T

Cancer Res 66, 803-811, 2006

Cited by (1)
36

EWS/FLI1 suppresses retinoblastoma protein function and senescence in Ewing's sarcoma cells

HU HM

J Orthop Res 26, 886-893, 2008

Cited by (1)
37

Soft tissue sarcomas of adults : State of the translational science

BORDEN EC

Clin Cancer Res 9, 1941-1956, 2003

Cited by (1)
38

Distinct mdm2/p53 expression patterns in liposarcoma subgroups : implications for different pathogenetic mechanisms

PILOTTI S

J Pathol 181, 14-24, 1997

Cited by (1)
39

Evaluation of MDM2 and CDK4 amplification by real-time PCR on paraffin wax-embedded material : a potential tool for the diagnosis of atypical lipomatous tumours/well-differentiated liposarcomas

HOSTEIN I

J Pathol 202, 95-102, 2004

Cited by (1)
40

Malignant peripheral nerve sheath tumor arising within neurofibroma. An immunohistochemical analysis in the comparison between benign and malignant components

WATANABE T

J Clin Pathol 54, 631-636, 2001

Cited by (1)
41

p15^<INK4b>, p14^<ARF>, and p16^<INK4a> inactivation in sporadic and neurofibromatosis type 1-related malignant peripheral nerve sheath tumors

PERRONE F

Clin Cancer Res 9, 4132-4138, 2003

Cited by (1)
42

Possible association between tumor-suppressor gene mutations and hMSH2/hMLH1 inactivation in alveolar soft part sarcoma

SAITO T

Hum Pathol 34, 841-849, 2003

Cited by (1)
43

Altered expression and molecular abnormalities of cell-cycle regulatory proteins in rhabdomyosarcoma

TAKAHASHI Y

Mod Pathol 17, 660-669, 2004

Cited by (1)
44

Comparative cytogenetic study of spindle cell and pleomorphic leiomyosarcomas of soft tissues : a report from the CHAMP Study Group

MANDAHL N

Cancer Genet Cytogenet 116, 66-73, 2000

Cited by (1)
45

PTEN/MMAC1 gene mutation is a rare event in soft tissue sarcomas without specific balanced translocations

SAITO T

Int J Cancer 104, 175-178, 2003

Cited by (1)
46

Genetic and epigenetic alterations of the PTEN gene in soft tissue sarcomas

KAWAGUCHI K

Hum Pathol 36, 357-363, 2005

Cited by (1)
47

PTEN and other tumor supressor gene mutations as secondary genetic alterations in synovial sarcoma

SAITO T

Oncol Rep 11, 1011-1015, 2004

Cited by (1)
48

Highly aggressive behavior of malignant rhabdoid tumor : a special reference to SMARCB1/INI1 gene alterations using molecular genetic analysis including quantitative real-time PCR

KOHASHI K

J Cancer Res Clin Oncol 133, 817-824, 2007

Cited by (1)
49

SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas

MODENA P

Cancer Res 65, 4012-4019, 2005

Cited by (1)
50

SMARCB1/INI1 protein expression in round cell soft tissue sarcomas associated with chromosomal translocations involving EWS : a special reference to SMARCB1/INI1 negative variant extraskeletal myxoid chondrosarcoma

KOHASHI K

Am J Surg Pathol 32, 1168-1174, 2008

Cited by (1)
51

Expression and genomic status of EGFR and ErbB-2 in alveolar and embryonal rhabdomyosarcoma

GANTI R

Mod Pathol 19, 1213-1220, 2006

Cited by (1)
52

Expression of receptor tyrosine kinases epidermal growth factor receptor and HER-2/neu in synovial sarcoma

THOMAS DG

Cancer 103, 830-838, 2005

Cited by (1)
53

Epidermal growth factor receptor blockade in combination with conventional chemotherapy inhibits soft tissue sarcoma cell growth in vitro and in vivo

REN W

Clin Cancer Res 14, 2785-2795, 2008

Cited by (1)
54

Hepatocyte growth factor and c-MET in benign and malignant peripheral nerve sheath tumors

RAO UN

Hum Pathol 28, 1066-1070, 1997

Cited by (1)
55

The MET receptor tyrosine kinase contributes to invasive tumour growth in rhabdomyosarcomas

REES H

Growth Factors 24, 197-208, 2006

Cited by (1)
56

Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumor)

HEINRICH MC

J Clin Oncol 24, 1195-1203, 2006

Cited by (1)
57

Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib : Imatinib Target Exploration Consortium Study B2225

MCARTHUR GA

J Clin Oncol 23, 866-873, 2005

Cited by (1)
58

Imatinib mesylate inhibits cell invasion of malignant peripheral nerve sheath tumor induced by platelet-derived growth factor-BB

AOKI M

Lab Invest 87, 767-779, 2007

Cited by (1)
59

E-cadherin gene mutations frequently occur in synovial sarcoma as a determinant of histological features

SAITO T

Am J Pathol 159, 2117-2124, 2001

Cited by (1)
60

E-cadherin mutation and Snail overexpression as alternative mechanisms of E-cadherin inactivation in synovial sarcoma

SAITO T

Oncogene 23, 8629-8638, 2004

Cited by (1)
61

SYT-SSX1 and SYT-SSX2 interfere with repression of E-cadherin by snail and slug : a potential mechanism for aberrant mesenchymal to epithelial transition in human synovial sarcoma

SAITO T

Cancer Res 66, 6919-6927, 2006

Cited by (1)
62

APC mutations in synovial sarcoma

SAITO T

J Pathol 196, 445-449, 2002

Cited by (1)
63

Hypermethylation of the APC promoter but lack of APC mutations in myxoid/round-cell liposarcoma

SIEVERS S

Int J Cancer 119, 2347-2352, 2006

Cited by (1)
64

Nuclear β-catenin expression distinguishes deep fibromatosis from other benign and malignant fibroblastic and myofibroblastic lesions

BHATTACHARYA B

Am J Surg Pathol 29, 653-659, 2005

Cited by (1)
65

β-Catenin nuclear expression correlates with cyclin D1 overexpression in sporadic desmoid tumours

SAITO T

J Pathol 195, 222-228, 2001

Cited by (1)
66

Nuclear β-catenin correlates with cyclin D1 expression in spindle and pleomorphic sarcomas but not in synovial sarcoma

SAITO T

Hum Pathol 37, 689-697, 2006

Cited by (1)
67

Possible association between higher β-catenin mRNA expression and mutated β-catenin in sporadic desmoid tumors : real-time semiquantitative assay by TaqMan polymerase chain reaction

SAITO T

Lab Invest 82, 97-103, 2002

Cited by (1)
68

Correlation between β-catenin widespread nuclear expression and matrix metalloprotease-7 overexpression in sporadic desmoid tumors

MATONO H

Hum Pathol 39, 1802-1808, 2008

Cited by (1)
69

The SYT-SSX1 variant of synovial sarcoma is associated with a high rate of tumor cell proliferation and poor clinical outcome

NILSSON G

Cancer Res 59, 3180-3184, 1999

Cited by (3)
70

High prognostic significance of Mdm2/p53 co-overexpression in soft tissue sarcomas of the extremities

WURL P.

Oncogene 16, 1183-1185, 1998

Cited by (2)
71

Prognosis is correlated with p53 mutation type for soft tissue sarcoma patients

TAUBERT H

Cancer Res 56, 4134-4136, 1996

Cited by (2)
72

Different expression profiles of Y-box-binding protein-1 and multidrug resistance-associated proteins between alveolar and embryonal rhabdomyosarcoma

ODA Yoshinao , KOHASHI Kenichi , YAMAMOTO Hidetaka , TAMIYA Sadafumi , KOHNO Kimitoshi , KUWANO Michihiko , IWAMOTO Yukihide , TAJIRI Tatsuro , TAGUCHI Tomoaki , TSUNEYOSHI Masazumi

Cancer Sci 99(4), 726-732, 2008-04-10

Ichushi Web References (35) Cited by (1)
73

Analysis of transforming activity of human synovial sarcoma-associated chimeric protein SYT-SSX1 bound to chromatin remodeling factor hBRM/hSNF2 alpha

NAGAI M

Proc Natl Acad Sci U S A 98, 3843-3848, 2001

Cited by (4)
74

Identification of p21WAF1/CIP1 as a direct target of EWS-Fli1 oncogenic fusion protein

NAKATANI F

J Biol Chem 278, 15105-15115, 2003

Cited by (2)
75

PAX3-FKHR transformation increases 26S proteasome-dependent degradation of p27^<Kip1>, a potential role for elevated Skp2 expression

ZHANG L

J Biol Chem 278, 27-36, 2003

Cited by (1)
76

Alterations of the p16^<INK4a>/p14^<ARF> pathway in clear cell sarcoma

TAKAHIRA Tomonari , ODA Yoshinao , TAMIYA Sadafumi , YAMAMOTO Hidetaka , KAWAGUCHI Kenichi , KOBAYASHI Chikashi , IWAMOTO Yukihide , TSUNEYOSHI Masazumi

Cancer Sci 95(8), 651-655, 2004-08-10

Ichushi Web References (43) Cited by (4)
77

Extrarenal rhabdoid tumors of soft tissue : Clinicopathological and molecular genetic review and distinction from other soft-tissue sarcomas with rhabdoid features

ODA Yoshinao , TSUNEYOSHI Masazumi

Pathol Int. 56(6), 287-295, 2006-06-01

Ichushi Web References (62) Cited by (5)
78

Expression of intercellular adhesion molecules in epithelioid sarcoma and malignant rhabdoid tumor

SAITO Tsuyoshi , ODA Yoshinao , ITAKURA Eijun , SHIRATSUCHI Hideki , KINOSHITA Yoshiaki , OSHIRO Yumi , TAMIYA Sadafumi , HACHITANDA Yoichi , IWAMOTO Yukihide , TSUNEYOSHI Masazumi

Pathol Int. 51(7), 532-542, 2001-07-01

Ichushi Web References (30) Cited by (5)
79

Truncating mutations of hSNFS/INI1 in aggressive paediatric cancer

VERSTEEGE I

Nature 394, 203-206, 1998

DOI Cited by (26)

Cited by: 1

Codes

NII Article ID (NAID)
10025141988
NII NACSIS-CAT ID (NCID)
AA11808050
Text Lang
ENG
Article Type

Journal Article
ISSN
13479032
Data Source

CJP CJPref